AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that ...
Please provide your email address to receive an email when new articles are posted on . The FDA has issued 510k clearance to Apollo Endosurgery’s Overstitch Sx, a new full-thickness endoscopic ...
OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...
AUSTIN, TX--(Marketwired - Apr 2, 2013) - Apollo Endosurgery, Inc., a company focused on the development of devices that enable a new generation of endoscopic surgical procedures, announced that its ...
AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
Shares of Apollo Endosurgery Inc. rocketed 28% in premarket trade Tuesday, after the medical device company said the Food and Drug Administration cleared its new flexibile endoscopic suturing system, ...
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback